• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Clinical outcomes of overlapping second-generation drug eluting stents in patients with diffuse coro

Clinical outcomes of overlapping second-generation drug eluting stents in patients with diffuse coro

来源 :第十二届中国介入心脏病学大会(CIT2014) | 被引量 : 0次 | 上传用户：daren19112879
【摘 要】
：
Background Second-generation drug eluting stents (DSE) associated with reduced major cardiac events compared to first-generation DES.However,limited data exists as to the clinical outcome of overlappi
【作 者】
：
Gao Fei Zhou Yujie Wang Zhijian Yang Shiwei LiuXiaoli Shen Hua 
【机 构】
：
Department of Cardiology,An Zhen Hospital,Capital Medical University,Beijing,China
【出 处】
：
第十二届中国介入心脏病学大会(CIT2014)
【发表日期】
：
2014年3期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Second-generation drug eluting stents (DSE) associated with reduced major cardiac events compared to first-generation DES.However,limited data exists as to the clinical outcome of overlapping second-generation drug eluting stents.
其他文献
Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of
Background It remains unclear whether intracoronary (IC) or intravenous (Ⅳ) administration of Tirofiban is superior for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary int
会议
Expression of microRNA-155 and microRNA-146a in peripheral blood mononuclear cells correlates with a
Background MicroRNA (miRNA) is a newly discovered endogenous non-coding single stranded RNAs,composed of 20-23 nucleotides,plays an important role in regulating in the process of cell differentiation,
会议
Performance of 2.25-mm diameter FIREHAWK abluminal groove-filled biodegradable polymer sirolimus-elu
Background Higher rates of adverse cardiac events and restenosis have been observed in patients with small vessel disease.The workhorse sizes of FIREHAWK abluminal groove-filled biodegradable polymer
会议
One-year results of everolimus-eluting stents for treatment of long coronary lesions:a subgroup anal
Background Long coronary lesions remain a higher risk of unfavorable outcomes after percutaneous coronary intervention and the stent length was recognized an independent factor for DES failure.No larg
会议
One-year results of everolimus-eluting stents for treatment of multivessel disease:a subgroup analys
Background The choice of revascularization strategy in multivessel coronary disease remains a critical issue in cardiology.No large-scale clinical study of everolimus-eluting Stents (EES) was conducte
会议
Impact of diabetes status on long-term (6 years) outcomes after percutaneous coronary intervention o
Background Scant data exist regarding the impact of diabetes mellitus (DM) status on percutaneous coronary intervention (PCI) for left main (LM) coronary artery disease.We sought to compare the impact
会议
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent
Background TARGET Ⅰ randomized controlled trial (RCT) demonstrated that the novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent FIREHAWK (MicroPort Medical,Shanghai,China) was
会议
富马酸喹硫平对精神分裂症急性期兴奋症状疗效的研究
目的 评价富马酸喹硫平600 ～ 750mg/d单药治疗精神分裂症急性期兴奋症状的疗效和安全性.方法 采用前瞻性、单组、开放性的设计,纳入符合ICD-10诊断标准的精神分裂症急性期患者124例,予喹硫平600～750mg/d单药治疗.观察时间为24周,在基线、治疗第1周末、第8周末及第24周末评估患者的治疗效果及安全性.疗效指标为阳性与阴性症状综合症量表(positive and negative
会议
富马酸喹硫平对精神分裂症急性期阴性症状和抑郁症状的疗效研究
目的 评价富马酸喹硫平单药治疗精神分裂症急性期阴性症状和抑郁症状的疗效.方法 采用前瞻性、单组、开放性的研究设计.纳入符合ICD-10精神分裂症诊断标准的124例精神分裂症急性期住院患者,予富马酸喹硫平600～750mg/d单药治疗,观察时间为24周,在基线、治疗第1周末、第8周末及第24周末评估患者的治疗效果及安全性.疗效指标为阳性与阴性症状综合征量表(PANSS)评分变化、蒙哥马利抑郁量表(M
会议
Clinical outcomes after percutaneous coronary intervention in acute myocardial infarction due to unp
Background Patients with acute myocardial infarction (AMI) with unprotected left main coronary artery (UPLMCA) as culprit lesion are a high-risk subgroup with a substantial mortality.Primary percutane
会议